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Introduction"

Periodontal disease is a world wide health problem. It is comprised of a

family of closely related acute and chronic inflammatory disorders affecting the
tissues housing the teeth. [1] Although a substantial research effort has been

devoted to studying the etiology, progression, and treatment of periodontal
diseases, there remains uncertainty regarding the specific processes resulting
in the expression of aspects of periodontal disease, including the

pathogenesis of periodontitis.
Periodontal disease involves the same immunological responses and

inflammatory mediators as those described for many other common
inflammatory disease processes. Similar to the multitude of diseases we
continue to confront in modern medicine, periodontal disease poses many

unanswered questions. Many of these questions pertain to the nature of
disease causation and the specific biological consequences of variables
believed to play a role in periodontal disease expression.

As stated in the 1989 Proceedings of the World Workshop in Clinical
Periodontics, the treatment of inflammatory periodontal disease has several
major therapeutic goals,
The immediate goal is to prevent, arrest, control, or eliminate
periodontal disease. The ideal goal would be to promote healing through regeneration of lost form, function, esthetics, and
comfort. When the ideal cannot be achieved, the pragmatic goal
of therapy would be to repair the damage resulting from disease.
The ultimate goal of therapy is to sustain the masticatory
apparatus- especially teeth or their analogues, in a state of
health. [2]

Clearly, this statement demonstrates the essence of the current goals of
periodontal treatment; namely, maintaining a healthy periodontium, while

halting destructive disease processes. An understanding of the complexities of
the disease process is essential to satisfy these goals.

The essential role of periodontal pathogens in promoting both

inflammatory disease (gingivitis) and destructive disease (periodontitis) is well
established. However, what is less well understood is the complex array of

interrelationships that exist among microorganisms and the host cells in such
disease processes. As Roy C. Page noted, "The aetiology of inflammatory

periodontal diseases can be considered in terms of the microorganisms
involved, the local environmental factors other than bacteria, and the role

played by the host defence systems" [1]. Over the past decade, advances in our
understanding of periodontal disease etiology and progression have been

enormous. Such progress has enabled periodontists to better understand
therapeutic interventions in treating and preventing disease. However, critical
issues regarding disease pathogenesis remain uncertain.

Gingivitis: Gingival Inflammatory Disease
Bacteria are a primary etiologic causative agent in inflammatory

periodontal diseases [1]. Gingivitis is defined as inflammation of the gingiva
and is the initial form of periodontal disease [3]. It precedes the destructive
lesion that characterizes periodontitis [4]. Gingivitis is initiated following the
accumulation of microbial plaque on and near the cervical region of the teeth

and its apical extension along the root surface [1, 5]. Bacterial plaque has been
shown to be the sole identifiable etiologic factor in gingival inflammation of

humans [6]. Numerous studies demonstrate the complexity of microorganisms
that compose the subgingival periodontal flora [7-13]. What is well accepted is
that a shift from health to gingivitis is characterized microbiologically by a

change from a gram-positive, predominantly non-motile streptococcal

subgingival microflora to a more complex flora including gram-negative and
spiral forms [1, 11, 14].

The initiation of gingivitis is multifactorial. According to a 1992 publication

by Genco, indirect mechanisms (host responses) combine with direct
mechanisms (bacteria and their products) to determine the intensity of the

inflammatory reaction in gingival tissue [15]. The importance of the host derived
factors can be demonstrated by the multitude of mediators found in gingival
crevicular fluid (GCF). These have been identified and studied in order to
determine their role in the pathogenesis of inflammatory periodontal disease.

Caffesse and Nasjleti suggested a role for hyaluronidase as a promoter for
bacterial collagenase penetration through intact gingival epithelium [16]. In a

1990 publication, Kunimatsu and coworkers noted activities similar to

cathepsins B,D,H, and L present in inflamed gingival tissue and in GCF from
inflamed sites [17]. Finally, neutral proteases resembling elastase, trypsin,

chymotrypsin, and other factors have been recovered in GCF from inflamed
sites [18], as have the cytokines IL-1 alpha and IL-1 beta [19], prostaglandin

E2

(PGE2) and a number of enzymes which are believed to play a role as important
proinflammatory mediators. In fact, the presence of prostaglandins, specifically

PGE2

in gingival crevicular fluid or corresponding tissue samples, correlates

directly with the severity of gingival inflammation in the adjacent tissues [20].
While an understanding of the biological consequences of host derived

factors is essential for a thorough understanding of the nature of disease

progression, the role of pathogenic bacteria, bacterial products, and the
resultant host response should be underscored. The inflammatory reaction or
series of reactions are "classic" and involve all inflammatory and immune cells

and cell products, as the various stages of inflammation progress. With the
initial accumulation of plaque, bacteria and/or their products adhere to or

penetrate tissue and thereby induce a host response through activation of
complement and the migration of PMNs [21].

As inflammation progresses,

antibodies and cytokines increase in level. When bound to bacteria, antibodies

promote complement binding and thereby stimulate phagocytes to engulf
bacteria [22]. Complement is activated by antigen- antibody reactions and

through the alternate pathway by various bacterial components [23]. One of

many bacterial components, lipopolysaccharide (LPS), is believed to play a
primary role in the pathogenesis of the destructive lesion that characterizes
periodontal disease [24, 25]. A series of enzymatic reactions then occur that
result in the release of C3a and C5a, which influence mass cell degranulation,
histamine release, and thereby an increase in vascular permeability. This series

of biological reactions, combined with leukocyte migration, results in stasis and

inflammatory exudate from vessels [15]. Both C3a and C5a, as well as the
bacterial product

FMLP act as chemoattractants for neutrophils [26]. Once

stimulated, neutrophils release products which mediate damage to host tissues

[27].
Gingivitis" Experimental Histopathology

In 1968, Thilander employed transmission electron microscopy in order
to study gingival biopsies from 12 gingivitis patients, and noted that crevicular
epithelium may become more permeable as inflammation progresses. The
author recognized slight changes characterized by vessel dilation, focal edema,

and increased epithelial spaces; moderate changes; and marked changes
suggestive of structural degeneration of the gingival apparatus [28].

In 1976, Page and Schroeder proposed a model that is consistent with
the pathogenesis of gingival inflammatory disease, as described [4]. According

to the authors, the histopathologic lesion of gingivitis may be described as

initial, early, and established. The "initial" lesion is a histological entity that

correlates with preclinical gingivitis. In humans it is seen within about four days

of the beginning of plaque accumulation [1]. During this initial stage, the

changes are subtle. They may be detected in the junctional epithelium and
perivascular connective tissue. There is an increase in the migration of

leukocytes which accumulate within the gingival sulcus and this can be
correlated with an increase in the flow of gingival fluid to the sulcus [29]. Other

findings include vasculitis of the vessels adjacent to the junctional epithelium
and gingival sulcus; presence of extracellular serum proteins, especially fibrin,
alteration of the most coronal portion of the junctional epithelium, and loss of

perivascular collagen [4]. The nature and character of the host response
determines whether this lesion resolves rapidly or evolves into a chronic

inflammatory lesion. If a chronic lesion evolves, an infiltrate of macrophages

and lymphoid cells appears within a few days [30].
The "early’ lesion correlates clinically with early gingivitis and appears 4

to 7 days following plaque accumulation. It is most notably characterized by a
dense lymphoid infiltrate. Collagen loss increases and lymphoid cells

accumulate and comprise approximately 75% of the infiltrate present.

Specifically, during the early lesion a histological examination of the gingiva
reveals a predominantly lymphocytic infiltration in the connective tissue

proximal to the junctional epithelium. Neutrophils, macrophages, plasma cells

and mast cells may also be present. The overall inflammatory cell response is
intensified relative to the initial lesion [31-35]. There is an increase in collagen

destruction, and alterations in blood vessel morphologic features and vascular

bed patterns are evident [36]. PMNs are found at increased levels in the

epithelium and emerging in the pocket area. Researchers note PMN attraction

to bacteria, phagocytosis and subsequent release of lysosomes [32].

The "established’ lesion correlates with chronic adult gingivitis. It occurs
2 to 3 weeks after the onset of plaque accumulation. The primary histo-

pathologic feature of the established lesion is the presence of plasma cells.
The lesion is characterized by the predominance of IgG and to a lesser degree

by IgA and IgM. Blood vessels become engorged and congested, venous return
is impaired and blood flow becomes sluggish [3]. The result is localized gingival

hypoxemia. Extravasation of red blood cells into the connective tissue and the

breakdown of hemoglobin may influence the clinical presentation of the gingiva

[3]. Histologically, continued loss of connective tissue is noted, and plasma cells
predominate without an appreciable loss of bone. Plasma cells invade the
connective tissue not only immediately apical to the junctional epithelium, but

also deep into the connective tissue, around blood vessels, and between

bundles of collagen fibers. The junctional epithelium reveals widened
intercellular spaces filled with granular cellular debris, including lysosomes

derived from disrupted neutrophils, lymphocytes, and monocytes. In the
connective tissue, collagen fibers are destroyed around the infiltrate of intact

and disrupted plasma cells, neutrophils, lymphocytes, monocytes, and mast

cells [37]. Established lesions of two types appear to exist; namely, those that
remain stable and do not progress for several months or years and those that

appear to become more active and convert to a progressive destructive lesion
[1]. The nature of this conversion has been studied; however, it remains to be
completely understood [38].

Periodontitis: Destructive Periodontal Lesion

Clinically, periodontitis may be characterized by periodontal pocket
formation, suppuration, tooth mobility and alveolar bone destruction. However,
the adult periodontitis lesion resembles the established lesion of gingivitis as

described by Page (1976), with the additional "spread" of inflammation into the

surrounding tissues and the development of attachment loss characterized by
alveolar bone loss and periodontal pocket formation.

According to a 1976 publication entitled "Pathogenesis of inflammatory
periodontal disease, A summary of current work", the following characterizes
the histopathologic features of periodontitis" Predominance of plasma cells,

continuing loss of collagen subjacent to the pocket epithelium, formation of
periodontal pockets, presence of altered plasma cells in the absence of altered
fibroblasts, extension of the lesion into bone and PDL with obvious loss of bone,

and widespread manifestation of inflammatory and immunopathologic tissue
reaction [4].

Histological examination reveals that pocket development between the
tooth surface and the gingiva, with apical displacement of the junctional

epithelium (JE), is the first indication of destructive disease [39]. Muller-Glauser
and Schroeder (1982) recognized thickening of the epithelium and rete ridge

development following replacement of the JE by pocket epithelium [40]. Microulceration of the pocket epithelium may occur and allow penetration of bacteria
and/or bacterial products. Such penetration may lead to a burst of disease

activity [39]. According to Takata and Donath, the initial JE defect is located
within the JE, as opposed to the JE/tooth interface [41]. A JE will develop, as

the pocket epithelium grows down the connective tissue/tooth interface.
Irreversible change, characterizing the periodontal destructive lesion, occurs as

the epithelium along the cementum/soft tissue interface prevents the
establishment of connective tissue reattachment [39].

Gingivitis (gingival inflammatory lesion) does not necessarily progress to
periodontitis (destructive periodontal lesion) and predicting which sites will
demonstrate clinical and or radiographic evidence of breakdown is difficult.

While gingivitis lesions may be transient or persistent, most are not progressive.

However, a small percentage can and do progress to periodontitis. While a
number of methods, including drug tests, sensitivity testing and a host of clinical
criteria may be employed to identify sites that may be at risk for breakdown, the

sensitivity and specificity of these tests do not consistently predict which sites

progress from inflammatory to destructive lesions. Ranney in a 1986
publication suggested that histologically, gingivitis has not been ruled out as a

necessary precursor to periodontitis, but it does not invariably progress to
periodontitis. Ranney suggests certain measures of host responses as
predictors of such a conversion [42].

It is important to recognize that additional variables play an important
role in our understanding of periodontitis and the progression of gingivitis to

periodontitis as described. For example, in a 1975 study by Lindhe and
coworkers entitled, "Plaque induced periodontal disease in beagle dogs", the
authors found that periodontitis might be prevented by calculus removal and
oral hygiene and that gingivitis can proceed to periodontitis. However, they

reported that in 2 of the 10 untreated animals some sites failed to progress to
periodontitis, suggesting a role for host susceptibility in the expression of
periodontitis. Such research lends support to the notion of a multifactorial basis
for periodontal disease establishment and its progression.
With a conversion to periodontitis, the subgingival flora at diseased sites
is predominantly gram-negative, anaerobic, and motile. While a host of

pathogens have been associated with changes that characterize destructive
periodontal lesions, those organisms which are most prevalent in adult

periodontitis include Porphyromonas gingivalis, Prevotella intermedia,
spirochetes, Eichenella and members of the genera Bacteroides and

Capnocytophaga. While the progression of adult periodontitis may be

associated with a characteristic microflora, and an association with clinical

attachment loss may implicate particular organisms in the pathogenesis of

periodontitis [43], the specific mechanisms by which these microorganisms and
their microbial products promote periodontal destruction remains surprisingly
controversial. Because bacterial invasion of gingival tissue is not a hallmark of
either gingivitis or periodontitis [37, 44], most believe that soluble microbial

products derived from subgingival organisms promote host inflammatory
reactions and destructive periodontal diseases [45, 46]. For example, Theilade

and coworkers demonstrated that the alteration in the proportion of bacteria in

plaque toward an increased percentage of gram negative microorganisms
paralleled the beginning of leukocyte migration into the gingiva [47]. Therefore,
it would appear that some substance produced by gram-negative organisms in
bacterial plaque causes the initial clinical and histologic signs of inflammation

that have been described [48].

Lipopolysaccharide (LPS)

LPS is a component of the cell wall of gram-negative bacteria and is
presumed to play a role in the changes associated with both inflammatory and
destructive periodontal disease processes [24, 25, 48-55]. The relationship of

LPS to the etiology of periodontal diseases is of interest when one considers
that LPS is a potent inflammatory agent. Because of its biological activity, LPS
is considered a primary pathogenic factor in inflammatory and destructive

processes. However, its precise role in inflammatory and destructive
periodontal disease pathogenesis is not entirely certain and therefore remains
controversial. For example, while the release of LPS from organisms within the

subgingival plaque has not been related to periodontal destructive processes, it
has been reported that LPS levels in gingival crevicular fluid have been

positively correlated with clinical and histologic signs of gingival inflammation

[48, 52].
Virtually all gram-negative periodontal pathogens possess
lipopolysaccharide (LPS) as a cell wall constituent [56]. The term endotoxin
describes a lipopolysaccharide component found on the outer membrane of the

cell wall of gram-negative bacteria. The term originates from early workers, such

as Pfeiffer (1892), who noted that "apart from the toxin released or shed into the
culture medium by living gram-negative microorganisms, exotoxin, additional
toxic substances were released coincident with the bacteria while undergoing

cellular lysis. It was believed that these substances were fixed to the bacterial

cell, hence the term endotoxin"[50].

LPS is known to be a potent toxin, and its injection into LPS-susceptible
animals produces fever, bone marrow suppression, white blood cell changes,

shock and death [57]. Injection of LPS into the skin or mucosa of a number of
animal species results in a local acute inflammatory reaction characterized by
increased vascular permeability, vasodilatation, accumulation of leukocytes,

and subsequent tissue damage[49, 54]. Drutz and Graybill (1978) reported that

30-60% of patients in the United States with gram- negative sepsis die despite
antibiotic therapy, possibly the result of the irreversible effects of LPS [58]. LPS

has the ability to activate the complement system, and thereby produces many
of its biological effects [59]. According to Garrison and coworkers, "These

responses have previously been used to compare the relative potencies of LPS
preparations; however, the capacity to elicit these pathologic responses may

not correlate with periodontal tissue destruction. Furthermore, LPS potencies
within these biological systems may not be related to the pathogenesis of

periodontal disease" [43].

As previously noted, bacterial plaque has been shown to be the sole
identifiable, etiologic factor for gingivitis in humans [6], and periodontitis in dogs

[60]. However, plaque microorganisms do not typically penetrate the gingival
tissue to any significant degree. As a result, cytotoxic and antigenic factors
derived from plaque micro- organisms diffuse into the tissue and thereby

produce those clinical and histological changes which characterize the
inflammatory lesion of gingivitis and the destructive changes of periodontitis

[45, 46, 50].
LPS and Gingival Inflammatory Disease

Many researchers have proposed that LPS has profound biological
influence. Bacterial LPS has been shown to stimulate macrophages to lyse

tumor target cells in vitro, involving direct cell to cell contact [61]. Ranney and

Montgomery found that endotoxin from Leptotrichia buccalis caused carbon
particle leakage from vessels of healthy gingiva. They concluded that LPS
likely penetrates the healthy crevicular epithelium to produce this effect and
therefore may be important in the early events of gingivitis [49]. Rizzo and

Mergenhagen conducted acute toxicity experiments in rabbit oral mucosa
following local inoculation of an endotoxin from an oral Veillonella organism.
The authors found that a single inoculation of 50 ug of this endotoxin resulted in

gross abscesses which persisted for up to 10 days. Additionally, inflammatory
lesions were accompanied by regional lymph node neutrophilic infiltration.

Finally, they found that a minimal dose of 1.0 ug of LPS produced a local
Schwartzman reaction, and an intramucosal inoculation of 1.0 ug of LPS
increased body temperature [54].

The effect of LPS on PMN migration and phagocytosis was examined by

Jensen and coworkers. LPS from Veillonella, when applied to the forearms of

human volunteers, produced an increase in both PMN migration and

phagocytic activity. According to Daly (1980), the authors concluded that the
increase in PMN migration observed during the experimental gingivitis studies

was due to the persistent irritation of capillaries by LPS [50, 62]. Additional

support for a possible role for LPS came from a 1967 investigation by
Mergenhagen. The author noted the potent toxicity of Veillonella LPS and
found raised serum antibody levels, to LPS prepared from Fusobacterium and
Vefllonella, in those patients with periodontitis [51].

LPS and Periodontal Destructive Lesions
LPS may play an important role in alveolar bone loss during periodontal
disease. The bone resorbing effect of LPS has been noted by a number of

investigators. In a 1970 publication by Hausmann et al., the authors
demonstrated that LPS stimulates the release of previously incorporated

4Ca

from fetal rat bone in tissue culture [63]. Millar et al. in a 1986 study of two
distinct isolates of LPS from Bacteroides gingivalis, demonstrated that both
isolates stimulated

45Ca release from prelabeled fetal rat bones and elicited a

30-40% reduction in collagen protein formation [64]. The authors concluded that
such findings may implicate LPS in alveolar bone loss associated with
periodontal disease. Raisz et al. demonstrated an interaction between
endotoxin and other factors thought to act as specific mediators of localized

bone resorption. They found that interaction between endotoxin and other bone

resorbing factors may produce unexpectedly large resorptive responses. Such
reactions may certainly be significant in the pathogenesis of bone loss in

periodontal disease [65]. Current research indicates that LPS may mediate its

effects on bone resorption through indirect mechanisms such as stimulation of

cytokine secretion from monocytes and macrophages with a resulting increase
in bone resorption by cytokines.

Inflammatory Mediators" Interleukin-1 and Prostaglandin- Role in
Periodontal Diseases
Periodontal diseases are characterized by both inflammatory and
destructive lesions. A number of mediators play specific roles in these

processes. As previously mentioned, both interleukin-1 (IL-1) and prostaglandin

(PG) play significant roles in periodontal disease presentation and
progression.
I1-1 can be produced by virtually all nucleated cell types, including all
members of the monocyte- macrophage lineage, B lymphocytes, natural killer

(NK) cells, T lymphocyte clones grown in cell culture, keratinocytes, dentritic
cells, astrocytes, fibroblasts, neutrophils, endothelial cells, and smooth muscle
cells [66]. Humans express 2 distinct molecular forms of IL-1, called IL-1 alpha
and IL-1 beta; each having similar biological activity and binding affinity to cell

surface receptors. Few tissues express IL-1 constitutively, while the majority of

cell types produce IL-1 only in response to external stimuli, such as bacterial

LPS. The principal effects of IL-1 alpha and beta are costimulation of antigen
presenting cells (APCs) and T cells, B cell proliferation and Ig production,

phagocyte activation, bone resoprtion, inflammation and fever, and
hematopoiesis [66].
The chronic inflammatory response associated with established gingivitis

or adult periodontitis results in elevated recovery of host derived soluble
mediators which include interleukins [67]. The predominant cell type recovered
in gingival connective tissue, regardless of the disease status, is the fibroblast

[68]. Gingival fibroblasts exposed to interleukin- 1 are capable of secreting

[69], a process which may account for a
large percentage of the prostaglandin E2 recovered in diseased gingival tissue.

elevated levels of prostaglandin E2,

At periodontitis sites, bone resorptive and inhibitory cytokines (IL-1 alpha, L-1
beta and TNF-alpha) in gingival tissue samples reach levels of 0.3, 11.7, and
0.4 ng/ml, respectively. Tissue samples from clinically healthy sites exhibit much

lower levels of these cytokines (0.07, 3.1, and 0.03 ng/ml, respectively) [70].

The identification of other biologically active substances produced by
host tissue in response to periodontal infection provides a direct means of

elucidating the mechanisms by which infection leads to loss of supporting
connective tissue and bone [71]. Tissue levels of prostaglandin t:: 2 are elevated
in inflamed as compared to normal periodontal tissues. Therefore it has been

postulated that

PGE2 plays a profound

role in gingival and periodontal diseases

[71]. This idea is supported by the ability of PGE2 to modulate inflammatory
reactions, immune reactions and bone resorptive processes [72]. In addition,

PGE2 levels are increased in the connective tissue in adult periodontitis lesions

[73, 74].
The production of

PGE2 in a biological system

involves multiple steps.

Activation of inflammatory cells causes a local release of arachidonic acid from

the cells. Such activity is catalyzed by phospholipase

A2. El Attar

demonstrated that inflamed periodontal tissue exhibits a substantial increase in
the level of free arachidonate [75]. This substance is metabolized oxidatively
via the cyclooxygenase pathway, and a potent bone resorbing hormone, PGE2,

PGE2 has been shown to stimulate bone resorption both in vitro
[76] and in vivo. [74] Goodson et al. in 1974 demonstrated that PGE2 is
is produced.

elevated in periodontal lesions [74]. Additionally, Offenbacher and coworkers
demonstrated that

PGE2 levels correlate with periods of periodontal disease

activity, is a relatively good diagnostic indicator of sites likely to demonstrate

tissue breakdown, and is recovered in elevated levels in crevicular fluid in direct

relation to

PGE2 levels in the juxtaposed gingival tissues [20, 77].

Periodontal Therapy Rationale: Role of LPS

Clearly, much is known about the nature and characteristics of
periodontal disease. In addition, many of the treatment modalities and their

efficacy are well understood and accepted as effective modes of therapy.
Conventional treatment of periodontitis may take the form of scaling and root

planing (mechanical removal of bacterial products) and/or surgical therapy.
The clinical benefits of scaling and root planing are derived from the

removal of subgingival plaque and calculus and the disruption of the

subgingival microbial flora and therefore a delay in the repopulation of

pathogenic microbes [78]. The indications for conventional periodontal surgical

therapy include access for root debridement, elimination of pockets by removal
and/or recontouring of soft or osseous tissues, removal of diseased periodontal

tissues, correction of mucogingival defects and establishment of gingival
architecture to facilitate oral hygiene and improve treatment prognosis [3].

Demonstration of the therapeutic benefit of scaling and root planing is the

result of the research efforts of many individuals [55, 79, 80]. Aleo and
coworkers studied the in vitro attachment of human gingival fibroblast cells to
the root surface of periodontally involved teeth. The author found that the

portion of root exposed to the destructive disease process had little or no cell

attachment. However, on the remainder of the unaffected root, the cells
attached normally. They concluded that clinical success would depend upon

complete removal of toxic materials from diseased cementum or the removal of
the cementum itself [79]. Their studies have shown that the cementum of

periodontally involved teeth exposed to the disease process contains

lipopolysaccharide or endotoxin; the remaining or uninvolved cementum is free
of endotoxin [79]. According to Ramjord (1980), bacterial products are

incorporated into the root cementum of periodontally diseased teeth; thus,
removal of contaminated cementum is considered the ultimate goal of root

surface debridement [80]. In contrast, Adelson and coworkers (1980)

investigated whether cultured fibroblasts will grow on heat sterilized
periodontally exposed root surfaces and whether root planing affects this

growth. The authors found no difference in pattern of cell growth, cell migration,
or cytotoxic reaction between root planed and non-root planed areas [81].

Alternate Theory: The Role of Hydroxy Fatty Acids and their
Relationship to Periodontal Disease
The preceding investigations offer scientific data regarding the role and
influence of LPS in periodontal diseases. However, others believe that an

alternate lipid, previously overlooked, may play a critical role in periodontal
destructive lesions. Current research points to a role for bacterial derived

hydroxy fatty acids in periodontitis, to the exclusion of LPS [56, 82, 83].

The

following is a summary of this evidence.
The toxic component of LPS is lipid A [84]. Lipid A contains the
characteristic 3-hydroxy bacterial fatty acids [85], some of which occur in
mammalian lipids with the exception of 3-OH

O:17:0. The 3-OH fatty acids of the

lipid A have been used as markers for detecting LPS in body fluids and other
specimens [86, 87]. Based upon the vast number of publications throughout the

past three decades, the periodontal community has apparently accepted that

LPS plays a prominent role in periodontal disease. However, the changes
associated with the onset of the gingival inflammatory lesion and the

subsequent progression to a destructive lesion of the periodontium, may be

incorrectly credited to LPS.

In a comparative study conducted by Lygre et al., samples of root
substance from healthy and periodontally diseased human teeth were analyzed
for fatty acids. The authors found that the content of the fatty acids C6:o, C6:,

C18:o and C8:

in the superficial layer of the periodontally diseased teeth was

significantly higher than that of healthy teeth. In the inner layer of the teeth, they
found no difference. The authors conclude that their mass- spectrometric
detection of 3-OH fatty acids demonstrated the presence of lipid A in the root

substance of single periodontally diseased teeth [24].

In a study designed to assess the distribution of 3-hydroxy iC17:0 in
subgingival plaque and gingival tissue samples and the relationship to adult
periodontitis, Nichols found elevated levels of 3-hydroxy iC17:0 within gingival
tissue lipids from periodontitis samples compared with healthy or mildly
inflamed samples. However, the elevated recovery of 3-OH

iC17:o in gingival

tissue could not be attributed to LPS, because the bacterial hydroxy fatty acid

was recovered primarily in complex lipids. This may indicate a role for 3hydroxy iC17:o containing lipids, other than LPS, in the pathogenesis of
periodontitis [56].

An understanding of the biological consequences of bacterial lipid
penetration into gingival tissues in adult periodontitis is essential to our
continued effort to define effective treatment modalities and to better predict
which areas are most likely to develop signs of disease. If bacterial lipid

penetration into gingival tissue is mechanistically linked to the expression of
adult periodontitis, the recovery of the bacterial lipid in gingival tissue should

directly correlate with alterations in host tissue behavior [83]. Are bacterial
lipids recoverable on tooth root surfaces and at what levels? Do such bacterial

lipids at these levels have biological effects on periodontal tissues, specifically
fibroblasts?

The primary objective of our study is to examine the distribution and

biological effects of bacterial lipids, other than LPS, recovered on diseased root

surfaces. Such biological effects could revolutionize approaches to periodontal

treatment. Specifically, they may enable us to critically evaluate our current

treatments and the fundamental principles which support such treatment
modalities

The present investigation seeks to define a role for such hydroxy fatty
acid containing lipids, other than LPS, in the pathogenesis of periodontitis.

Specifically, we will first define and quantify hydroxy fatty acids in lipids
recovered from periodontally diseased teeth and their corresponding plaque

samples prior to extraction. Secondly, we will quantify hydroxy fatty acids in
lipids recovered from diseased roots before and after thorough root planing and
scaling. These experimental trials are essential, as the relevant biological levels
of bacterially derived lipids must be estimated prior to initiating an assessment
of the effects of these lipids on cultured mammalian fibroblast cells. Because

the bacterial lipids of the type examined in the present study are virtually
insoluble in aqueous medium and these bacterial lipids are thought to gain

entry into periodontal tissues through novel cell presentation mechanism/s and
transport, the lipids recovered in our study must be provided to cells in culture
such that the physical environment mimics the tooth/plaque-tissue interface in
human periodontal tissues. Given our understanding of the predominance of
fibroblasts in gingival connective tissue, [68] their expected exposure to
bacterial lipids in diseased periodontal tissues, [56, 83] and their secretion of

impressive levels of PGE2, our final goal will assess the biological influence of
defined quantities of bacterial lipids by investigating their direct influence on

mammalian gingival fibroblast secretory function, cell growth and recovery.

Furthermore, we will examine the effect of interleukin-1 on prostaglandin
secretion from gingival fibroblasts after exposure to either P. gingivalis or

calculus lipids known to contain the hydroxy fatty acids of interest.

Study Objective"
Experiment 1"

To quantify hydroxy fatty acids in lipids recovered from
individual teeth and corresponding plaque samples taken from

around each tooth immediately prior to extraction. The results of such
experimental trials will help to define the specific fatty acid components present
in periodontally diseased root surfaces. Prior to initiating an assessment of the
bacterial lipid effects on gingival fibroblast cell recovery and function, the

relevant biological levels of these fatty acids must be determined. Moreover, by

determining the quantity of such fatty acids on both tooth surfaces and
corresponding plaque samples, we may develop an understanding of the
potential that may exist for selective adsorption of such bacterial products.
The application of phospholipid extraction procedures [88] to plaque and

tooth samples would be expected to separate bacterial lipids, recovered in the

organic solvent phase, from LPS, which remains in the aqueous phase.
Assuming that bacterial hydroxy fatty acids are not also synthesized in human
tissues, the recovery of covalently linked hydroxy fatty acids in aqueous and

organic extracts of biological samples should provide an indirect assessment of
the quantity of LPS- and lipid- associated hydroxy fatty acids. Of the common
bacterial hydroxy fatty acids, most can be synthesized in mammalian tissues

during either beta or alpha oxidation processes, although in different epimer
forms. However, previous reports have not demonstrated 3-hydroxy i017:0

synthesis in mammalian tissues exist. Therefore the recovery of 3-hydroxy i017:o
in organic solvent and aqueous extracts of biological samples should reflect the

2O

recovery of bacterial lipids or LPS, respectively, from those organisms
containing 3- hydroxy iC17:0.

A comparison of the percentage of this particular fatty acid present in the
complex lipids to that present in LPS, may support the notion that LPS is not a
primary causative factor. In fact, we hypothesize that it is not LPS, but rather 3

hydroxy iC17:o containing lipids, that are critical to periodontal destruction and
therefore to periodontal treatment success.

Methods and Materials"
Lipid Extraction and Separation"
Teeth destined for extraction were evaluated both clinically and

radiographically. Those teeth chosen demonstrated at least 50% bone loss
radiographically and clinical evidence of severe periodontitis. Plaque samples
from at least six aspects of each tooth were taken by placing course endodontic

paper points into the sulcus for 10 seconds and transferring the paper points to
glass tubes for processing. Teeth and plaque samples were immediately frozen
and processed by the phospholipid extraction procedure of Bligh and Dyer as
modified by Garbus [88, 89]. Water (0.5 ml) and 2 ml of CHCI3- methanol (1 "2

vol/vol) were added to each sample, and the samples were immediately
vortexed. After standing for at least 2 hours, 0.75 ml of CHCI3 and 0.75 ml of 0.5

M K2HPO4 and 2 M KCI were added to each sample and vortexed. The lower
CHCI3 phase, or lipid phase, was removed and dried under N2 gas. The
aqueous phase, expected to contain LPS, was retained, and the hydroxy fatty
acid content was analyzed by gas chromatography- mass spectrometry.
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Lipid Analysis by gas Chromatography-mass spectrometry:

All derivitizing agents were obtained from Pierce Chemical Corp.

(Rockford, III.). Nonadecanoic acid was added to each sample of LPS isolate or
lipid fraction. When alkaline hydrolysis was employed, the samples were
treated with 4N KOH (0.5 ml., 100 C, 90 min.), and the hydrolysate was
acidified with concentrated HCI. The acidified samples were then extracted with

CHCI3 (1 ml, three times) and the pooled extracts were dried under a stream of
N2 gas.The dried fatty acid samples were dissolved in acetonitrile (30ul) and
treated with 35% pentafluorobenzyl bromide in acetonitrile (10ul) and

diisopropylethylamine (10 ul). The solution was heated for 20 minutes at 40 C
and evaporated to dryness under

N2 gas. The resultant pentafluorobenzyl

esters were treated with N-O-bis(trimethylsilyl)-trifluoroacetamide (50 ul) and
incubated overnight. The lipid derivatives were applied to a Hewlett Packard

model 5890 gas chromatograph interfaced with a model 5988A mass

spectrometer. Samples were applied to an Ultra-1 column (12mm x 0.2mm x

0.2um) held at 100 C. Samples were injected using the splitless mode and a
temperature program of 2 C per minute to 240 C. The mass spectrometer was
used in the negative-ion-chemical ionization mode with an ion source

temperature of 100 C, an electron energy of 240 eV, and an emission current
of 300 mA. Methane was used as the reagent gas and was maintained at
0.75 torr.

Known amounts of 2-hydroxy C4:o, C6:o, and C8:0 and 3-hydroxy C4:o,

C16:o, C17:o and C8:0 were analyzed for selected ion retention times and signal
responses relative to the internal standard (C19:o). Quantification of hydroxy fatty
acids from bacterial samples was accomplished by using selected ion

monitoring of the appropriate base peak ions, and extraction losses were
corrected by using the

C19:o internal

standard.
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Results

A comparison of the hydroxy fatty acid recoveries in organic extracts from
teeth and plaque samples is seen in Figure1. Statistically significant
differences regarding the percent of total fatty acid recovered in the organic

extract is evident for 3-OH C6:o (p=.0016), 3-OH C7:o (p=.0016) and 2-OH

C14:0 (p=.0321). The percentage of total fatty acid recovered in organic extract
differed between plaque and teeth samples for specific fatty acids. A greater

percent of 3-OH C6:0 was observed in lipids from plaque samples, than in
corresponding lipid extracts from teeth samples, while the opposite held true for

3-OH

C17:O and 2-OH O14:O, where a greater percentage of fatty acid was

recovered in the organic extracts from teeth samples than in corresponding

plaque samples.

As is evident in Figure 1, the percent recovery of 3-OH C4.0 or 2-OH

C6:0 in organic solvent extracts was not significantly different when comparing
teeth with corresponding plaque samples.
With regard to 3-OH C7:0, approximately 60% of total fatty acid was

recovered in the organic extract, while the remaining fatty acid, presumed to be

incorporated into LPS, was present in the aqueous phase. A process of
selective adsorption may account for the elevated recovery of bacterial lipid

containing 3-OH

C17:0 on root surfaces, when compared with 3-OH C17:o

containing lipid in plaque. This is consistent with a report by Nichols who noted,
"The fact that bacteria containing 3-hydroxy isobranched

C17:0 are not

recovered in significant levels within diseased gingival tissue suggests that the

presence of periodontal microorganisms may have little bearing on the lipid
penetration process other than to provide the ceramide lipid for adsorption to
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root surfaces" [82]. The results presented in this thesis therefore support the
possibility of bacterial lipid adsorption to diseased tooth roots.

Experment 2:
To quantify hydroxy fatty acids in lipids recovered from
diseased roots before and after thorough root planing/ scaling. This

assessment determined the relevant levels of bacterial or calculus-tooth lipids
for testing in cultures of mammalian fibroblast cells.

It was our aim to quantify the amount of hydroxy fatty acids present in
both diseased and non-diseased root surfaces. Diseased root surfaces were
those which demonstrated gross calculus deposits by visual inspection, while

treated root surfaces were those which demonstrated a similar degree of
calculus prior to treatment consisting of thorough root planing and scaling.

Methods and Materials:

Teeth, extracted from one patient with a diagnosis of generalized severe
adult periodontitis, were frozen until processed. Prior to extraction,

approximately 15 plaque samples were taken from this same patient and

analyzed in the same manner described in goal one. Teeth were randomly
assigned either to a control group or to a scaling and root planing group. Using

a high speed handpiece, fifteen root sections with visible calculus were

prepared by making a cut parallel to the tooth surface. The sections were made
into the dentin approximately lmm in depth, careful not to include pulp tissues.

These root sections comprised the "diseased" sample group as previously
defined. Additional root surfaces where calculus was visibly evident were

scaled with an ultrasonic scaler and hand curettes. Each sample was treated
until all visible calculus was removed and the root surface appeared clinically

smooth. These root sections comprised the treated sample group. Each sample
within its appropriate group was handled and treated in the same manner.

Windows of these visibly cleaned root surfaces were sectioned in the identical

manner as the calculus "preserved" sites. Each of the 30 sections obtained

were photographed using a calibrated lens setting, followed by placement of
tooth sections into an individual glass tube for lipid extraction. The photographic
slides were then projected and paper tracings were cut to fit the root sections.

Additionally, a standard square was cut and photographed for increasing

surface areas (i.e. 2x2 mm 2, 4x4 mm 2, etc.). Each cutout of root slices and
surface area standards were weighed on a Metier balance and the surface area
of each root section was determined using a standard curve generated from

paper cutouts of known surface area. The surface area standards, between
surface area of paper cutout and weight, formed a perfect linear relationship.
Additional teeth contaminated with calculus were extracted in order to obtain a

sample of tooth/calculus lipid for biological testing.Porphyromonas gingivalis

was grown in pure culture and lyophilized and the dried bacterial pellet was
extracted for bacterial lipids. Subgingival plaque, tooth and root section

samples, as well as P. gingivalis (~ lmg) were extracted overnight using the
method of Bligh and Dyer, and as modified by Garbus.

Specifically, 0.5 ml of H20 + 2.0 ml of MeOH:CHCI3 (2"1 v/v) were added

to each sample vial and were shaken and vortexed. After 12 hours, 0.75 ml 2 N

KCI + 0.5 ml K2HPO4 + 0.75 ml CHCI3 were added to each sample and
vortexed. From each sample, the lower phase was carefully removed. An
additional 0.75 ml

CHCI3 was added to each sample and vortexed.

The lower

phase was removed and combined with the appropriate previously removed
organic extract. Each sample was dried under

N2 gas followed by the addition

of 344 ug of OH:C19:0 (aqueous:organic). To each organic extract, 0.5 ul HCI

KOH was added followed by heating for 90 minutes at 95 C. Each of the
samples were then extracted twice with 2ul hexane. The hydroxy fatty acids

were then derivatized in order to make them volatile for analysis on the gas
spectrophotometer. (refer to pp. 21-22)

Recovery of bacterial hydroxy fatty acid in lipid extracts of unscaled and
scaled root sections were calculated per unit surface area (ng 3-OH

isoC7:o/mm2). These values were then averaged for the untreated and scaled
teeth. Using the recovery of 3-OH isoC17:o/ug in lipid extract of P. gingivalis (ng

3-OH isoC7:0/ug of P. gingivalis lipid), the mass of P. gingivalis to apply to 35

mm culture wells was calculated. The calculation of the equivalent amount of P.
gingivalis lipid needed in each culture well amounted to approximately 170 ug.
This value applies only to untreated root surfaces. This value was considered to

be an excessive amount of lipid for biological testing and therefore as a starting

values we chose to apply 10ug or 50ug of lipid to each culture dish well as

described, for our additional experiments. Hence, the value chosen was lower

than the maximum value calculated. The lipid extract of P. gingivalis was
dissolved in ethanol at the appropriate dilution and 20 ul of lipid solution was

deposited into each culture well and allowed to dry overnight, while maintained
in a laminar flow hood.

Recovery of 3-OH isoC17:0 in lipid extracts from cleaned root surfaces (ng
3-OH isoC17:o mm 2) was used to determine the level of calculus- tooth lipid
extract to apply to culture wells.

Results"

Recovery of 3-OH iso C17:0 in organic extracts was evaluated using tooth
root slices before and after calculus removal. These results show 3-OH isoC17:o

recovery primarily in lipids of teeth and untreated root samples (58% and 67%,
respectively, of the total 3-OHisoC7:o ). Scaling of teeth reduced the percent
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recovery of 3-OHisoC17:o in lipid extracts (44% of the total 3-OHisoC17:o
recovered) (See Figure 2).
The results shown in Figure 3 demonstrate the recovery of 3-OHisoC17:o,
measured in ng/mm2, from root surfaces that are contaminated with calculus or

from cleaned root surfaces. Most but not all microbial lipids were removed by

scaling and root planing as described. The recovery of 3-OHisoC17:o in lipid

extracts from cleaned root sections was calculated to be 57.68 pg/mm2. This
value converts to 55.49 ng of 3-OHisoC7:0 added to each 35mm culture well

employed in further experimental trials, in order to achieve a concentration of
calculus- tooth lipid equal to that recovered on clean root surfaces. Given that
1.295 ng of 3-OHisoC7:o is recovered per ug of calculus-tooth lipid, this value

translates to 43 ug of calculus-tooth lipid/culture plated into each 35mm culture
well. In order to assess the effects of calculus-tooth lipid on gingival fibroblasts

at a level equivalent to cleaned root surfaces, 50 ug of calculus-tooth lipid was

placed into each culture well.
The mean recovery of 3-OHisoC7:0 in lipids from calculus-laden root

surfaces was 1,682 ng/mm2. The recovery of 3-OHisoC7:o in P.gingivalis lipids

was 22ng/ug, indicating that 74ug of lipid from P.gingivalis should be deposited
into each 35mm culture well in order to achieve the equivalent level of bacterial

lipid recovered on untreated root surfaces. For our present experiments

designed to evaluate P. gingivalis lipid effects on gingival fibroblasts, only 10ug

or 50ug aliquots of P. gingivalis lipid were plated into each 35mm culture well.

Experiment 3"

Using the average levels of bacterial lipid recovered from diseased root
surfaces of defined area, cultured fibroblasts were treated with calculus lipid at

a relevant concentration identified in goal 2. This allowed us to determine the
effect of the bacterial lipid on fibroblast secretory function and growth in culture.

We hypothesize that bacterial lipid applied at or below the concentration
defined by our previous study, will have a significant effect upon fibroblast cell

number and recovery. Additionally, a specific number of cell culture dishes will
be treated with L-1 beta, with and without the bacterial lipid.

Therefore, the goal of this study was to determine the effect of
calculus lipid on fibroblast secretory function and growth as
measured by recovered cells. We will determine the effect of calculus lipid
and P. gingivalis lipid, with and without IL-1 beta on fibroblast secretion of

PGE2

The level of prostaglandin production by fibroblasts will be determined through

a prostaglandin extraction procedure. An increase in PGE2 production is
expected based upon our understanding of the production of

PGE2 by

fibroblasts in the presence of disease, as well as the work of previous

investigators. At the end of each treatment, the cells will be released with
trypsin, thereby enabling us to assess the incorporation of calculus lipid, as

measured by the recovery of 3-OH C17:0 in extracted complex lipids. This study
will enable us to support our hypothesis, by demonstrating that lipids of

calculus promote secretory responses in gingival fibroblasts. This may prove
significant in the tissue destructive events that characterize and define
periodontitis.

3O

Materials and Methods"

Primary cultures of gingival fibroblasts were obtained using gingival
tissue explants harvested at the time of periodontal surgery. The explants were

initially placed in minimum essential medium (MEM) (Gibco, Grand Island, New

York) containing 10% fetal calf serum (Hyclone, Provo, Utah) and amphotericin
B (2.5ug/ml), penicillin G (1000 U/ml), and streptomycin (1 mg/ml), and
transported to the laboratory. The method used to culture fibroblasts is that
described by Richards and Rutherford in a 1988 publication. The explants were

placed in MEM and supplemented with 10% fetal calf serum, amphotericin B

(1.25 ug/ml), penicillin G (500U/ml), and streptomycin (500ug/ml) and minced
into small pieces. After cell monolayers had grown from the tissue explants, the
minced tissue pieces were aspirated from the culture dishes and the cell

monolayers grown to nearly confluence in MEM containing 10% fetal calf

serum, amphotericin B (0.25 ug/ml), penicillin G (100U/ml), and streptomycin
(100ug/ml). The cells were passaged using trypsin 0.1% in Ca, Mg-free
phosphate buffered saline and resuspended in MEM with 10% fetal calf serum,
penicillin G (100U/ml), streptomycin (100ug/ml) and amphotericin B (25ug/ml).

For all subsequent passaging of cells, fibroblasts were diluted approximately
1:4 with each passage and were subcultured for approximately ten passages

before starting fresh primary cultures. Cells were cultured in an
5%

H20 saturated,

CO2 atmosphere at 37 C.
Primary cultures of gingival fibroblasts were prepared from healthy

gingival tissue samples. The effects of P. gingivalis and calculus- tooth lipids

were assessed using the respective lipid extracts, at the levels defined in our
previous experiments, plated directly into 35mm culture wells and allowed to

dry. Control wells were treated with ethanol vehicle. Gingival fibroblasts were

inoculated onto the lipid films and allowed to grow for 7 days, exchanging old
medium with fresh medium at 3 day intervals. At seven days, the culture
medium was supplemented with human recombinant interleukin-1 beta

(Immunex Corporation, Seattle, A) to achieve a final concentration of 10 ng/ml.
Culture supernatants were collected after 48 hours of cytokine treatment and

prostaglandin levels determined in the medium samples by gas

chromatography- mass spectrometry. The adherent cells were released from
culture dishes with trypsin 0.1% in Ca, Mg-free phosphate buffered saline

(2ml/well). Each culture dish was then rinsed with an additional 2 ml of
phosphate buffered saline and pooled with the original washing. In order to
determine cell recovery, an aliquot of the cell suspension was counted

electronically (Coulter Counter) and the cells were centrifuged (1000 x g for 5

min.). The pelleted cells were frozen until lipid extraction and analysis of
bacterial fatty acid recovery in fibroblast lipid extracts.

Quantification of

prostaglandin levels in medium samples"

Prostaglandin levels in fibroblast culture medium samples were
determined using gas chromatography- mass spectrometry. The thawed
medium samples were supplemented with 100ul of D4-PGF2alpha and D4-

PGE2 (approximately 500 ng/sample of gingiva, Cayman Chemical Co.). The
filtrates were adjusted to pH 3.5 with formic acid by adding approximately 100
ul/ml of concentrated formic acid. Reverse phase C-18 columns (Supelcoclean,

Supelco, Bellefonte, PA) were regenerated by first eluting 3 ml of 100%
methanol followed by 3 ml of PBS (pH 3.5). The acidified medium samples

were then eluted over the regenerated C-18 columns. The columns were then
washed with 3ml of 25% methanol in water and the prostaglandins were

recovered by eluting 3 ml of 100% methanol. Recovered prostaglandin samples

were then supplemented with 3 ml of 1% formic acid and extracted with CHCI3

(3 x 2ml). The organic solvent extracts were dried under nitrogen.

As previously described, all derivatizing agents were obtained from
Pierce Chemical Corp., Rockville, IL. Prostaglandin samples were derivatized

using the method of Waddell et al. (46). Eicosanoid samples were first treated
with 2% methoxylamine hydrochloride in pyridine (50 ul). After standing

overnight, the samples were dried under nitrogen, dissolved in acetonitrile (30

ul) and treated with pentafluorobenzyl bromide (35% v/v in acetonitrile, 10ul)
and diisopropylethylamine (10ul). The samples were vortexed, incubated for 20
minutes at 40oc and evaporated under nitrogen gas. The residue was then

treated with bistrimethylsilyl-trifluoroacetamide (BSTFA, 50ul) and allowed to

stand for 4-5 days. Hydroxy fatty acids were derivatized for gas

chromatography-mass spectrometry as described in earlier methods and
materials.
Derivatized products of hydroxy fatty acids and prostaglandins were then

transferred to vials used for GC-MS automated sampling (crimp cap vials, 200

ui). Prostaglandin derivatives in BSTFA were diluted 1"1 (v/v) with hexane
when transferred to the automatic sampling vials whereas the hydroxy fatty acid
derivatives were transferred without dilution. Derivatized prostanoid samples

frequently formed precipitates when transferred to the GC-MS vials. If carried
with the liquid sample into the

gas chromatograph, the precipitate could

interfere with gas flow through the capillary column. This problem was avoided

by vortexing the samples and centrifuging at 2,000 rpm for 10 minutes. The
liquid supernatant was then aspirated and transferred to a new crimp cap vial.

Gas chromatography-mass spectrometry was carried out for
prostaglandins on a Hewlett Packard 5890-gas chromatograph interfaced with
a 9988A-mass spectrometer. Samples were applied to an HP-1 (Ultra-I, 12 m x
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0.2 mm, Hewlett Packard) column held at 100oc. Hydroxy fatty acid samples

were injected in the splitless mode (30 sec) and the column heated at 10OC/min

to 200oc followed by 2OC/min to 270oc. Prostanoid samples were analyzed
using a temperature program of 2OC/min from 100oc to 240oc. The injector
block was held at 260oc. The mass spectrometer was used in the negative ionchemical ionization mode with the source temperature at 100oc, the electron

energy at 240 eV and the emission current of 300 mA. Methane was used as
the analyte gas and was maintained at 0.5 torr in the ion source. Product levels

were quantified using selected ion monitoring of the characteristic base peak
ions for prostanoids and hydroxy fatty acids. The recovered prostanoid and

hydroxy fatty acid levels were normalized based on the tissue sample mass.

Recovery of OH fatty acid in gingival fibroblasts
Hydroxy fatty acid analysis by gas chromatography-mass

spectrometry: The dried fatty acid extracts were dissolved in acetonitrile (30ul) and
treated with 35% pentafluorobenzylbromide in acetonitrile (10ul) and

diisopropylethylamine (10ul). The solution was then heated for 20 min at 40oC and

evaporated to dryness under N2 gas. The resultant pentafluorobenzyl esters were
then treated with N,O-bis(trimethylsilyl)-trifluoroacetamide (50ul) and incubated

overnight. The lipid derivatives were applied to a Hewlett Packard 5890-gas

chromatograph interfaced with a 5988A-mass spectrometer. Samples were applied
to an Ultra-1 column (12 m x 0.2 mm, Hewlett Packard, Avondale, PA) held at 100C.

Samples will be injected using the splitless mode and a temperature program of
2C/min to 240oC. The mass spectrometer was used in the negative ion-chemical

ionization mode with the ion source temperature of 100C, the electron energy of 240

eV and an emission current of 300 mA. Methane is used as the reagent gas at 0.75
torr. Quantification of hydroxy-fatty acids from biological samples was accomplished
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using selected ion monitoring of the appropriate base peak ions of hydroxy fatty acids
and extraction losses were corrected using the recovery of the

C19:0 internal standard.

Known amounts of 2-hydroxy-C4:o,-C16:o and -C8:o and 3-hydroxy C14"0,C16:0,-iC17:0 and -O18:0 (Matreya, Inc.) were analyzed for characteristic spectra,
selected base-peak ion retention times and signal responses relative to the

C19"0

internal standard. The base peak ion for each fatty acid constitutes 60-80% of the total
ion abundance detected for each fatty acid standard and accounts in large part for the

very high sensitivity of this mass spectrometric technique. Derivatives of each hydroxy
fatty acid standard were individually applied to the GC-MS and the resultant fatty acid
peak was evaluated in the total ion scan mode (50-800 m/z, dwell time: 10

milliseconds) for its characteristic mass spectral pattern. The base peak ion for each

hylroxy fatty acid derivative was determined from the total ion mass spectra and for
these products, the base peak ion corresponded to the (M-PFB)-ion of each hydroxy

fatty acid. The hydroxy fatty acids derivatives were then run in the selected ion mode
and the retention times for each base peak ion were determined. The elution program
and mass spectrometer parameters, are described above. The

C19:0 represents the

internal standard, a fatty acid which is not recovered from either bacterial or human

cells. The results demonstrated the characteristics of the pentafluorobenzyl-ester form
of O19:0, which is the final derivatized form of this fatty acid after the processing
described above.

Detection limits for these substances are in the low picogram

range. Furthermore, alkaline or acid hydrolysis does not cause measurable
degradation of hydroxy fatty acid standards (data not shown).

Results

Recovery of Fibroblasts after treatment with Interleukin-1 with or
without bacterial lipid

Figure 4 demonstrates the recovery of gingival fibroblasts from culture
dishes following treatment with 1% trypsin in PBS (w/v). Cells were harvested

after 48 hours of exposure to interleukin-lbeta alone, or interleukin-lbeta
combined with P. gingivalis lipid or calculus-tooth lipid. When compared with

cells treated with interleukin-lbeta alone, fibroblast cell growth was inhibited by

approximately 50% when cells were exposed to P. gingivalis lipid (50ug
lipid/culture well) together with interleukin-lbeta. In addition, fibroblast cell

growth was inhibited with calculus-tooth lipid plus interleukin-lbeta by
approximately 20%. However, this difference was not statistically significant.

Recovery of Hydroxy Fatty Acids in lipid extracts of Gingival
Fibroblasts

Figure 5 demonstrates the recovery of 3-OHisoC7:o in lipid extracts of
gingival fibroblasts following harvesting the cells with 1% trypsin in PBS (w/v).

Recovery of 3-OHisoC7:o in gingival fibroblasts treated with 50ug of
P.gingivalis lipid plus interleukin-lbeta was significantly elevated when

compared to control cultures treated with interleukin-lbeta alone. The recovery
of P. gingivalis lipid in cells represented approximately 10% of the bacterial
lipid that was originally placed into the culture well based on the recovery of 3OHisoC17:o in the harvested cells. The recovery of 3-OHisoC17:o in lipid extracts

of fibroblasts treated with calculus lipid plus interleukin-lbeta was also
elevated. However, the recovery of calculus lipid in the fibroblasts represented
approximately 50% of the original bacterial lipid deposited into the culture wells

based on the recovery of 3-OHisoC17:o in fibroblast lipid extracts.

Prostaglandin release from gingival fibroblasts in culture
treated with interleukin-1 beta

Figure 6 demonstrates the effect of 10ug of P. gingivalis lipid on
interleukin-lbeta mediated prostaglandin secretion from fibroblast cells. Control

fibroblasts and those exposed to 10ug of P. gingivalis lipid secreted negligible

amounts of prostaglandin 52. Additionally, 50ug of P. gingivalis lipid did not
stimulate secretion of prostaglandin

E2 from fibroblasts. However, with exposure

of fibroblasts to 10ng/ml of human recombinant interleukin-lbeta, a dramatic
increase in prostaglandin

E2 secretion was observed.

Furthermore, following

cell exposure to 10 ug of bacterial lipid plus interleukin-lbeta, prostaglandin

E2 secretion

increased by an additional 15%.

Figure 7 demonstrates the effects of P. gingivalis lipid or calculus-tooth
lipid on interleukin-lbeta-mediated secretion of prostaglandin

52 and F2aipha

from fibroblasts.Gingival fibroblasts treated with 50ug of P. gingivalis lipid

extract plus 10ng/ml of interleukin-1 beta secreted three times more
prostaglandin

52 and F2alpha than those cells treated with

interleukin-lbeta

alone. Fibroblasts treated with 50ug of calculus-tooth lipid plus interleukin1beta also secreted three times more prostaglandin

E2 than cells treated with

interleukin-lbeta alone. While the effect on prostaglandin

was not statistically significant.

F2alpha was positive it

General Discussion"
The experiments described herein demonstrate the recovery of bacterial

lipid containing 3-OH iSO017:0 on diseased root surfaces before and after

scaling and root planing. Given an understanding of the proximity and

biological inter-relationship between tooth root surfaces and adjacent
periodontal soft tissues, the present investigation demonstrated that such lipids

are capable of substantially potentiating L-1 beta-mediated secretion of
prostaglandin from gingival fibroblasts. This increased level of prostaglandin
secretion from gingival fibroblasts may in turn promote disease expression. The

preceding experimental trials may also define an important mechanism,

previously overlooked, by which periodontal pathogens alter host responses

perhaps to the extent that destructive periodontal disease is expressed.
Furthermore, while establishing a role for 3-OH isoC7:0- containing lipids in the
pathogenesis of periodontitis, the previously accepted theory of LPS and

periodontal disease causation is brought into question.
The recovery of the bacterial hydroxy fatty acid, 3-OH isoC17:o, in organic
and aqueous solvent extracts of plaque samples, teeth, and root sections

provided an indirect measure of bacterial complex lipid and lipopolysaccharide
levels, respectively [56]. The bacterial hydroxy fatty acid, 3-OHisoC7.0, is
recovered only in Porphyromonas, Prevotella, Bacteroides, Capnocytophaga

[90, 91], Fiavobacterium and Myxobacteria genera, but is not synthesized by
mammalian tissues. Flavobacterium and Myxobacteria are not reported to be
constituent organisms of subgingival plaque and the recovery of 3-OH

isoC17:o

in organic and aqueous solvent extracts of plaque and gingival tissue samples
is presumed to reflect the recovery of Porphyromonas, Prevotella, Bacteroides

and Capnocytophaga species only [56]. Therefore, recovery of 3-OHisoC7:o in

gingival lipids is presumed to represent penetration of particular bacterial lipids
into the tissue under examination.

The present investigation employed aqueous and organic solvent
partitioning techniques in order to quantify hydroxy fatty acids recovered from
teeth, corresponding plaque samples and root sections before and after scaling
and root planing. The procedures employed would be expected to separate
bacterial lipids, recovered in the organic solvent phase, from LPS, which
remains in the aqueous phase. Assuming that bacterial hydroxy fatty acids are

not also synthesized in human tissues, the recovery of covalently linked hydroxy

fatty acids in aqueous and organic extracts of biological samples should
provide an indirect assessment of the quantity of bacterial LPS- and lipidassociated hydroxy fatty acids. Given our understanding of the origin of 3-OH

/so017:0, its recovery in organic solvent and aqueous extracts of biological
samples should reflect the recovery of bacterial lipids or LPS, respectively, from
those organisms containing 3-OH/SO017:0 [56]. The present study demonstrated
that the majority of 3-OH/SO017:0 (--62% of the total in subgingival plaque

samples is recovered in the aqueous phase, most likely in lipopolysaccharide.
According to our study design, subgingival plaque samples were isolated from
periodontally-hopeless teeth immediately prior to tooth extraction. According to
Figure 1, approximately 58% of 3-OH isoC7:o from periodontally hopeless teeth

was recovered in lipid extracts. In addition, results from experimental trial 2
indicate that 67% of the total 3-OH/so017:0 recovered from root samples with
visible calculus was recovered in lipid extracts. In contrast, 58% of the total 3-

OH/so017:0 in P.gingivalis, was recovered in organic solvent extract. According
to Nichols (unpublished data), Prevotella, Bacteroides, and Capnocytophaga

generally incorporate 3-OH isoC17:o into lipids to a lesser degree than P.
gingivalis. Therefore, if tooth roots were contaminated with P. gingivalis only,
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the recovery of 3-OH

iso017:0 would not be greater than 58% of the total [56].
Given that 3-OH /SO017:0 is recovered in lipid extracts of calculus contaminated
root surfaces to a greater degree than that recovered in both plaque samples

and P. gingivalis, these results support the argument that bacterial lipids

containing 3-OH/so017:0 are selectively adsorbed to tooth root surfaces and

may be concentrated in or on subgingival calculus deposits. A process of
selective adsorption may account for the elevated recovery of 3-OH/SO017:0 on
root surface lipids when compared with 3-OH isoC17:o containing lipid in

plaque.

As noted, 67% of the total 3-OH/SO017:0 recovered from root samples
with visible calculus present was recovered in lipid extracts. Given the

predominant recovery in lipid, one may argue that 3-OH isoC17:0 has a

propensity for mineralized tissue. Similarly, the preferential adsorption of
bacterial lipid to root surfaces may be related to the release of complex lipid

from bacterial cell walls through cell death, cell degradative processes, or cell
membrane modification. With regard to gingival tissue samples, 3-OH isoC17:o
is recovered virtually only in organic extracts, with negligible levels noted in

aqueous extract. Bacterial LPS is therefore either destroyed, cleared or fails to
enter gingival tissues. Furthermore, if LPS is not present in gingival tissues, the
organisms synthesizing 3-OH isoC17:o are likely not present as well [56].
Unpublished data demonstrates that at least 80% of 3-OH

isoC17:o

present in gingival tissue is recovered in the subjacent connective tissue lipids.
This would indicate that bacterial lipids containing 3-OH

isoC17:o penetrate into

gingival connective tissue through overlying epithelium. Additional research is
needed to investigate the possibility that these lipids, which selectively adsorb

to root surfaces and therefore appear to have an affinity for mineralized tissues,

may be capable of exerting effects on both cementum and bone. Should this be

4O

found to be true, it would have a substantial effect on our understanding of the
pathogenesis of the periodontal destructive lesion.
Given our understanding of the characteristics of periodontal disease as
described, as well as the apparent affinity of 3-OH

iSO017:0 for mineralized

surfaces, one may suggest that root surfaces contaminated with bacterial lipids

can provide a reservoir of lipids for penetration into gingiva directly contacting
the root surface. Such a process would depend on the diffusion characteristics
of the lipids in host cell membranes and their diffusion potential on
contaminated root surfaces. The present investigation provides evidence to

support the notion of a lipid reservoir, by demonstrating that the lipids of P.
gingivalis and subgingival calculus are taken up by gingival fibroblasts, likely

through incorporation into the fibroblast cell membrane. Therefore, the present
study provides a model for investigating the incorporation of bacterial lipids into
host cells, as a possible explanation for bacterial lipid recovery in gingival
tissues without direct bacterial invasion.

It is known that diseased gingival tissues demonstrate elevated levels of

PGE2. Prostaglandins are considered to be important proinflammatory and
tissue destructive mediators. While many bacterial and host derived factors are

known to stimulate prostaglandin secretion from host cells in vitro, there is little
evidence demonstrating a direct correlation between bacteria and/or bacterial

factors and prostaglandin levels in tissue samples [83]. In the present study, the

primary objective was to assess and define the biological influence of complex
lipids on host cells, specifically their potentiation of fibroblast prostaglandin
secretion. The effects of bacterial lipids on fibroblast secretory function were
determined using lipid isolates from P. gingivalis or calculus contaminated-

teeth. Biologically relevant levels of lipid were determined by assessing

recovery of 3-OH/so017:0 on calculus contaminated root surfaces before and

after thorough scaling and root planing. The maximum amount of calculus-tooth
lipid deposited on culture dish surfaces was based on the level of 3-OH isoC7.o

recovered on cleaned tooth surfaces. In the present study, fibroblast growth was
inhibited and interleukin-lbeta-mediated prostaglandin secretion was

significantly stimulated, following application of calculus-tooth lipid to culture

dishes at a level approximating that recovered on cleaned root surfaces. In
addition, exposure of gingival fibroblasts to P. gingivalis lipid at a level below

that recovered on root surfaces contaminated with calculus, markedly interfered
with cell growth and resulted in significant stimulation of interleukin-1 beta-

mediated prostaglandin secretion. Finally, application of P. gingivafis lipid at a

level that is only slightly greater than the amount of 3-OH isoC17:o recovered on

cleaned root surfaces, resulted in slight stimulation of prostaglandin secretion
that was not statistically significant.

Significant changes in fibroblast secretory function following application
of both P. gingivalis lipid and calculus- tooth lipid, at the levels recovered on
cleaned root surfaces, provide support for a new paradigm regarding

periodontal disease pathogenesis. The lipid extract from calculus contaminated

root surfaces was more potent than the lipid extract from P. gingivalis (based on
the levels of

3-OHisoC7:o per unit mass of lipid applied to culture dishes). In

order to further support a hypothesis regarding the influence of bacterial

hydroxy fatty acids on fibroblast cell recovery and prostaglandin secretory
function, we completed an assessment of the uptake of 3-OH

isoC7:o in

fibroblast lipids after treatment with interleukin 1-beta. Following completion of

the culture period, we noted that only 10% of the P. gingivalis lipid plated onto
culture dishes was recovered in fibroblasts, while 50% of the 3-OH isoC7:ocontaining lipid in calculus-tooth lipid was recovered in fibroblasts. Therefore,
the bacterial lipids containing 3-OH

isoC7:o recovered in calculus-tooth lipid
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extract, possess a greater capacity for incorporation into gingivai fibroblasts.
More importantly, this may account for the strength of the biological influence
noted.

Summary and Conclusions:
Periodontal disease is influenced by a host of risk factors that we
continue to more accurately define. However, the intricacies of periodontal
disease pathogenesis remain a subject of continued research. The present

investigation demonstrated that bacterial lipids adsorbed to diseased root
surfaces can penetrate into gingival tissues and potentiate interleukin-1 betamediated secretion of prostaglandins from gingival fibroblasts. Specifically, an
elevation in interleukin-1 beta associated with inflammatory periodontal lesions,

results in an increase in prostaglandin

E2 levels more in the presence of P.

gingivalis and calculus-tooth lipid than in their absence. This finding may serve

as a basis for redefining the nature of periodontal disease pathogenesis. In
addition, the preceding experimental trials and results may have profound

implications regarding our understanding of the biology and treatment of
periodontal disease.
Until we discover the true pathogenesis of periodontitis, our ability to

predictably treat disease will remain limited. Is periodontal disease, or rather

adult periodontitis, a lipid disease? The findings of the present investigation
and the subsequent model developed, suggest that periodontal disease may be

significantly influenced by bacterial lipids.

In summary, the present investigation sought to define a role for hydroxy
fatty acid containing lipids, other than LPS, in the pathogenesis of periodontitis.
Specifically, we determined the recovery of bacterial lipids containing 3-OH

/so017:0 on diseased root surfaces before and after root planing and scaling.
The relevant lipid levels were then employed for exposure to gingival fibroblasts
in culture. The present study demonstrated that lipid extracts obtained from both

P. gingivalis or calculus-contaminated tooth surfaces are capable of
43
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significantly potentiating interleukin 1-beta secretory responses in gingival
fibroblasts. This may serve as a basis for further inquiry as we redefine

periodontal disease pathogenesis and the treatment of periodontal disease.

Figure 1

Comparison of hydroxy fatty acid
Recoveries in Organic Extracts from Teeth
and Plaque Samples
3-OH 14:0

! 3-OH 16:0
3-OH 17:0
2-OH 14:0
F’l 2-OH 16:0

Percent of
Total Fatty Acid
Recovered in
Organic Extract
20

0

Teeth

Plaque

Sample

45

p=.0016
p=.0016
p=.0321

46

Figure 2

n=15

80

Percent of
3-OH C17:0
Recovered in

n=14

60

40

Organic Extract
20

Plaque

Teeth

Untreated

Scaled Root

Root Samples Samples

47
Figure 3

2000

Aqueous Extract
Organic Extract
3-OH C17:0
2

1000

pg/mm

Untreated Root

Scaled and Root

Samples

Planed Samples

48
Figure 4

10

Cell Number
ng/million cells
2

Control
(n=6)

Total lipid Calculus lipid
(n=6)
(n=3)

Treatment
*significantly different from controls, p<0.05 by oneway factorial ANOVA

49
Figure 5

50
40

3-OH C17:0
ng/million cells

30
20

10

Control
(n=6)

Total lipid Calculus lipid
(n=3)
(n=6)

Treatment
*significantly different from controls, p<0.05 by oneway factorial ANOVA

50
Figure 6

300

T
PGE 2

ng/million cells

2OO

100

Control

lipid

IL-1 lipid plus
IL-1

Treatment

51

Figure 7

"V-

Prostaglandin
(ng/million cells)

2

PGE
PGF

i
Control
(n=4)

Total lipid
(n=4)

Calculus lipid
(n=2)

Treatment
*

significantly different from controls, p < 0.05 by oneway factorial ANOVA

2
2

References
1.

Page RC. Current understanding of the aetiology and

progression

of

periodontal disease. International Dental Journal,

1986. 36: p. 153-161.
2.

Periodontology, A.A.P. Annals

of

Periodontology in World

Workshop in Clinical Periodontics. 1989.
3.

Carranza F. Glickman’s Clinical Periodontology. 7th ed. 1990,

Philadelphia: W.B. Saunders Co.

Page R, Schroeder H. Pathogenic Mechanisms, in Periodontal
Disease: Basic Phenomena, Clinical Management and Restorative
Interrelationships, S. Schluger, R. Youdelis, and R. Page, Editors. 1977,
4.

Lea and Febiger" Philadelphia.
Schroeder H, Attstrom R. Pocket formation." an hypothesis, in
The Borderland Between Caries and Periodontal Disease H, T. Lehner

5.

and G. Cimasoni, Editors. 1980, Academic Press: London. p. 99.

6.

Loe H, Theilade E, Jensen S. Experimental gingivitis in man.

Journal of Periodontology, 1965. 36" p. 177-187.
7.

Newman MG, Socransky SS, Savitt ED, et al. Studies on the

microbiolgy

of periodontitis.

Journal of Periodontology, 1976. 47" p.

373-379.
8.

Slots J. Subgingival

microflora and periodontal

disease. Journal

of Clinical Periodontology, 1979. 6" p. 351-382.

9.

Tanner AC, Haffer C, Bratthall GT, et al. A study of the bacteria

associated with advancing periodontitis in man. Journal of Clinical

Periodontology, 1979. 6" p. 278.

52

53
10.

Slots JH, Reynolds HS, Genco RJ. Actinobacillus

actinomycetemcomitans in human periodontal disease" a cross
sectional

microbiological investigation. Infection and Immunity,

1980. 29" p. 1013.

1 1.

Moore W, Holdeman LV, Simbert RM,

et al. Bacteriology

of

experimental gingivitis in young human adults. Infection and

Immunity, 1982. 38" p. 651.
12.

Zambon JL, Christersson LA, Slots J. Actinobacillus

actinomycetemcomitans in human periodontal disease, prevalence in
patient groups and distribution

families.
1 3.

of biotypes

and serotypes within

Journal of Periodontology, 1983. 54" p. 707.

Socransky S, Haffajee AP, Goodson JM, et al. New concepts of

destructive periodontal disease. Journal of Clinical Periodontology,

1984. 11" p. 21.
14.

Loe H, Silness J. Periodontal disease in pregnancy. I. Prevalence

and severity. Acta Odontologica Scandinavica, 1963. 21" p. 533.

15.

Genco R. Host responses in periodontal diseases" current

concepts. Journal of Periodontology, 1992. 63(suppl 4)" p. 338-355.

16.

Caffesse R, Nasjleti C. Enzymatic penetration through intact

sulcular epithelium. Journal of Periodontology, 1976. 47" p. 391-397.
17.

Kunimatsu K, Yamamoto K, Ichimaru E, et al. Cathepsin B, H and

L activities in gingival crevicular fluid from chroni’c adult
periodontitis patients and experimental gingivitis subjects. Journal of
Periodontal Research, 1990. 25" p. 69-73.

Cox S, Eley B. Detection of cathepsin b- and 1-, elastase-,
tryptase-, trypsin-and dipeptidyl peptidase IV- like activities in
1 8.

crevicular

fluid from gingivitis and periodontitis patients

with

54

peptidyl derivatives

of

7-amino-4-trifluoromethyl coumarin. Journal

of Periodontal Research, 1989. 24" p. 353-361.
19.

Masada MP, Persson R, Kenney JS, et al. Measurement

interleukin-la and-lb in gingival crevicular

the pathogenesis

of periodontal

of

fluid." Implications for

disease. Journal of Periodontal

Research, 1990. 25" p. 156-163.
20.

Offenbacher S, Odle BM, Gray RC et al. Crevicular

prostaglandin E2 levels as a measure
status

of

of

fluid

the periodontal disease

adult and juvenile periodontitis patients. Journal of

Periodontal Research, 1984. 19’ p. 1-13.

21.

Miyasaki K. The neutrophil" mechanisms

of

controlling

periodontal bacteria. Journal of Periodontology, 1991. 62" p. 761764.
22.

Kinane DF, Winstanley FP, Adonogianaki E, et al. Bioassay

interleukin 1 (IL-1) in human gingival crevicular

of

fluid during

experimental gingivitis. Archives of Oral Biology, 1992. 37 p. 153156.
23.

Montgomery E, White R. Kinin generation in the gingival

inflammatory response in topically applied bacterial

lipopolysaccharides. Journal of Dental Research, 1986. 65" p. 113117.

24.

Lygre H, Solheim E, Gjerdet NR,

et al.

Fatty acids of healthy and

periodontally diseased root substance in human teeth. Journal of
Dental Research, 1992. 71" p. 43-46.

25.

Slots J, Dahlen G. Subgingival microorganisms and bacterial

virulence

factors

in periodontitis. Scandinavian Journal of Dental

Research, 1985. 93" p. 119-127.

55
26.

Schenkein H. The role

of complement

in periodontal disease.

Critical Reviews in Oral Biology and Medicine, 1991. 2" p. 65-81.

27.

Altman LC, Baker C, Fleckman P, et al. Neutrophil-mediated

damage to human gingival epithelial cells. Journal of Periodontal
Research, 1992. 27" p. 70-79.
28.

Thilander H. Epithelial changes in gingivitis- An electron

microscopic study. Journal of Periodontal Research, 1968. 3" p. 303-

312.
29.

Attstrom R, Egelberg J. Emigration of blood neutrophils and

monocytes into the gingival crevices. Journal of Periodontal Research,

1970. 5" p. 48-55.

30.

Page R, Ammons W, Simpson D. Host

tissue respone in chronic’

inflammatory periodontal disease" IV. The periodontal and dental
status

of

a group

of aged

great apes. Journal of Periodontology, 1975.

46" p. 144.
3 1.

Gavin J. Ultrastructural

features of

chronic marginal gingivitis.

Journal of Periodontal Research, 1970. 5" p. 19.

32.

Lange D. and Schroeder H. Cytochemistry and ultrastructure of

gingival sulcus cells. Helvetica Odontologica Acta, 15 (Suppl 6), 1971.
81" p. 65-86.
33.

Lindhe J, Schroeder HE, Page RC, et al. Clinical and stereologic

analysis

of

the course

of early

gingivitis in dogs. Journal of

Periodontal Research, 1974. 9" p. 314.

34.

Listgarten M, Ellegaard B. Experimental gingivitis in rhesus

monkeys. Journal of Periodontal Research, 1973. 8" p. 199.

56
35.

Payne WA, Page RC, Ogilvie AL, Hall WB. Histopathologic

features of

of

the initial and early stages

experimental gingivitis in

man. Journal of Periodontal Research, 1975. 10" p. 51.

36.

Hock J, Nuki K. A vital microscopy study

normal and

of

the morphology

of

Periodontal Research, 1971.

inflamed gingiva. Journal of

6" p. 81.
37.

Freedman H, Listgarten M, Taichman N. Electron microscopic

features of

chronically inflammed human gingiva. Journal of

Periodontal Research, 1968. 3" p. 313.

38.

Schroeder H, Lindhe J. Conversion

of

established gingivitis in

the dog into destructive periodontitis. Archives of Oral Biology, 1975.

20" p. 775.
39.

Gillett I, Johnson N, Curtis M. The role

diagnosis and progression

of periodontal

of

histopathology in the

disease. Journal of Clinical

Periodontology, 1990. 17" p. 673-684.
40.

Muller-Glauser W, Schroeder H.

The Pocket Epithelium." A light

and electron microscopic study. Journal of Periodontology, 1982. 53"

p. 133-144.
41.

Takata T, Donath K. The mechansim

of pocket formation.

Journal of Periodontology, 1988. 59" p. 215-221.

42.

Ranney R. Discussion" Pathogenesis of gingivitis. Journal of

Clinical Periodontology, 1986. 13" p. 356-359.

43.

Garrison S, Holt S, Nichols F. Lipopolysaccharide-stimulated

PGE2 release

from

human monocytes" Comparison

lipopolysaccharides prepared

of

from suspected periodontal pathogens.

Journal of Periodontology, 1987. 59" p. 684-687.

57
Ellison S. Oral bacteria and periodontal disease. Journal of

44.

Dental Research, 1970. 49" p. 198-202.

Socransky S. Relationship of bacteria to the etiology of

45.

periodontal disease. Journal of Dental Research, 1970. 49" p. 203222.

46.

Kelstrup J, Theilade E. Microbes and periodontal disease.

Journal of Clinical Periodontology, 1974. 1" p. 15-35.
47.
in

Theilade E, Wright W, Jensen S, Loe H. Experimental gingivitis
man"

H. A longitudinal clinical and bacterial investigation. Journal

of Periodontal Research, 1966. 1" p. 1-13.
48.

Simon BI, Goldman, H, Ruben M, Baker E. The role

in periodontal disease" III. Correlation

of

of endotoxin

of endotoxin in
degree of inflammation.

the amount

human gingival exudate with the histologic

Journal of Periodontology, 1971. 42" p. 210-216.

49.

Ranney RR, Montgomery EH. Vascular leakage resulting from

topical application

of

endotoxin to the gingiva

of

the Beagle dog.

Archives of Oral Biology, 1973. 18" p. 963-970.

50.

Daly CG, Seymour GJ, Kieser JB. Bacterial endotoxin." A role in

chronic inflammatory periodontal disease. Journal of Oral Pathology,

1980. 9" p. 1-15.

Mergenhagen S. Nature and significance of somatic antigens of
oral bacteria. Journal of Dental Research, 1967. 46" p. 46-52.
5 1.

52.

Simon BI, Goldman H, Ruben M, Baker V. The role

in periodontal disease" H. Correlation

of

the quantity

human gingival exudate with the clinical degree
Journal of Periodontology, 1970. 41" p. 81-86.

of

of endotoxin
endotoxin in

of inflammation.

58

5 3.

Simon B I, Goldman H, Ruben M, et al. The role

periodontal disease" IV. Bacteriologic analyses
exudate as related to the quantity

inflammation. Journal
54.

of

of

of endotoxin

in

human gingival

endotoxin and clinical degree

of

of Periodontology, 1972. 8" p. 468-475.

Rizzo A, Mergenhagen S. Histopathologic

effects of

endotoxin

injected into rabbit oral mucosa. Archives of Oral Biology, 1964. 9" p.

659-670.

55.

Aleo JJ, DeRenzis FA, Farber PA, et al. The presence and biologic

activity

of

cementum bound endotoxin. Journal of Periodontology,

1974. 4" p. 672-675.

56.

Nichols FC. Distribution

of 3-hydroxy

iC17.’0 in subgingival

plaque and gingival tissue samples" Relationship to adult
periodontitis.

57.

Infection and Immunity, 1994. i2" p. 3753-3760.

Nowotny A. Molecular aspects of endotoxin reactions.

Bacteriological Reviews, 1969. 33" p. 72-98.

Drutz D, Graybill J, eds. Infectious Diseases. 2 ed. Basic and
Clinical Immunology, ed. H. Fudenberg, et al. 1978, Lange Medical
58.

Publications" Los Altos. p. 595-596.

59.

Gewurz H, Shin H, Mergenhagen S. Interactions

of

the

complement system with endotoxic lipopolysaccharide" Consumption

of each of the

terminal complement components. Journal of

Experimental Medicine, 1968. 128" p. 1049-1057.
60.

Lindhe J, Hump S, Loe H. Experimental periodontitis in the

beagle dog. Journal of Periodontal Research, 1973. 8" p. 1-10.
61.

Doe W, Henson, P. Macrophage stimulation by bacterial

lipopolysaccharides. I. Cytolytic

effect

on tumour taget cells. Journal

of Experimental Medicine, 1978. 148" p. 544-556.

59

62.

Jensen S, Theilade E, Jensen J. Influence of oral bacterial

endotoxin on cell migration and phagocytic activity. Journal of
Periodontal Research, 1966. 1" p. 129-140.

63.

Hausmann E, Raisz L, Miller W. Endotoxin" Stimulation of bone

resorption in tissue culture. Science, 1970. 168 p. 862-864.

64.

Millar SJ, Goldstein EG, Levine MJ, Hausmann E. Modulation

of

bone metabolism by two chemically distinct lipoloysaccharide

fractions from bacteroides gingivalis. Infection and Immunity, 1986.
51" p. 302-306.

65.

Raisz L, Nuki K, Alander CB, Craig RG. Interactions between

bacterial endotoxin and other stimulators

of

bone resorption in organ

culture. Journal of Periodontal Research, 1981. 16" p. 1-7.

66.

Oppenheim J, Ruscetti F, Faltynek L. Cytokines, in Basic and

Clinical Immunology, D. Stites, A. Terr, and P. Tristram, Editors. 1994,

Prentice Hall International" London.

67.

Honig J, Rordorf-Adam C, Siegmund C, et al. Increased

interleukin-1 beta (IL-1 beta)concentration in gingival tissue

from

periodontitis patients. Journal of Periodontal Research, 1989. 24" p.

362-367.
68.

Schroeder HE, Munzel-Pedrazzoli S, Page RC. Correlated

morphometric and biochemical analysis

of

gingival tissue in early

chronic gingivitis in man. Archives of Oral Biology, 1973. 18" p. 899-

923.

69.

Richards D, Rutherford RB. The

effects of

interleukin-1 on

collagenolytic activity and prostaglandin E secretion by human
periodontal ligament and gingival

Biology, 1988. 33" p. 237-243.

fibroblasts.

Archives of Oral

6O
70.

Stashenko P, Jandinski JJ, Fujiyoshi P, et al. Tissue levels

of

bone resorptive cytokines in periodontal disease. Journal of

Periodontology, 1991. 62" p. 504-509.

7 1. Dewhirst FE, Moss DE, Offenbacher S, Goodson JM. Levels of
prostaglandin E2, thromboxane, and prostacyclin in periodontal
tissues. Journal of Periodontal Research, 1983. 18" p. 156-163.

72.

Stenson W, Parker C. Prostaglandins, macrophages, and

immunity. Journal of Immunology, 1980. 125" p. 1-5.

73.

Mendieta CF. Biosynthesis

of prostaglandins

in gingiva

of

patients with chronic periodontitis. Journal of Periodontology, 1985.

56" p. 44-47.
74. Goodson JM, Dewhirst FE, Brunetti A. Prostaglandin E2 levels
and human periodontal disease. Prostaglandins, 1974. 6" p. 81-85.

75.

E1Attar TMA, Lin HS, Killoy WJ, et al. Hydroxy fatty acids and

prostaglandin formation in diseased human periodontal tissue.
Journal of Periodontolal Research, 1986. 21" p. 169-176.

76.

Klein DC, Raiz LG. Prostaglandins: Stimulation

of

bone resorption

in tissue culture. Endocrinology, 1970. 86" p. 1436-1440.

77.

Offenbacher S, Odle B, Van Dyke T. The use

prostaglandin E2 levels as a predictor

of crevicular fluid

of periodontal

attachment loss.

Journal of Periodontal Research, 1986. 221" p. 101-112.

78.

Mousques T, Listgarten MA, Phillips RW. Effect of scaling and

root planing on the composition

flora.
79.

of

the human subgingival microbial

Journal of Periodontal Research, 1980. 15" p. 144-151.
Aleo J, DeRenzis F, Farber P. In vitro attachment

gingival fibroblasts to root
46" p. 639.

surfaces.

of

human

Journal of Periodontology, 1975.

61
80.

Ramfjord S. Root planing and curettage. International Dental

Journal, 1980. 3t1" p. 93-100.
8 1.

Adelson LJ, Hanks CT, Famjford SP, Caffesse RG. In vitro

cytotoxicity

of periodontally

diseased root

surfaces.

Journal of

Periodontology, 1980. 51" p. 700-704.
82.

Nichols FC. Novel ceramides recovered

from Porphyromonas

gingivalis: relationship to adult periodontitis. Journal of Lipid
Research, 1998. 39" p. 2360-2372.
83. Nichols FC, Maraj B. Relationship between hydroxy fatty acids
and prostaglandin E2 in gingival tissue. Infection and Immunity,
1998. 66" p. 5805-5811.

84.

Hitchcock PJ, Leive L, Makela H, et al. Lipopolysaccharide

nomenclature-past, present, and

future.

Jounal of Bacteriology, 1986.

166" p. 699-705.

85.

Jantzen E, Bryn K. Whole-cell and lipoloysaccharide fatty acids

and sugars

of gram-

negative bacteria, in Chemical Methods in

Bacterial Systematics, M. Goodfellow and D. Minnikin, Editors. 1985,
Academic Press" London.

86.

Jantzen E, Bryn K. Whole-cell and lipolysaccharide fatty acids

and sugars

of

gram-negative bacteria, in Chemical Methods in

Bacterial Systematics, M. Goodfellow and D. Minnikin, Editors. 1985,

Academic Press" London.

87.

Maitra S, Nachum R, Pearson F. Establishment

of beta-hydroxy

fatty acids as chemical marker molecules for bacterial endotoxin by
gas chromatography-mass spectrometry. Applied and Environmental

Microbiology, 1986. 52" p. 510-514.

62
88.

Bligh EG, Dyer WJ. A rapid method

purification. Canadian Journal of

of total

lipid extraction and

Biochemistry and

Physiology,

1959. 37" p. 911-917.
89.

Garbus J, DeLuca HF, Loomas ME, Strong FM. Rapid

incorporation

of phosphate

into mitochondrial lipids. Journal of

Biological Chemistry, 1968. 238" p. 59-63.
90.

of

Johne B, Bryn K. Chemical composition and biological properties
a lipopolysaccharide

from

Bacteroides intermedius. Acta

Pathologica, Microbiologica, et Immunologica Scandinavica

Section

B, Microbiology, 1986. 94" p. 265-271.
9 1.

Johne B, Olsen I, Bryn K. Fatty acids and sugars in

lipopolysaccharides

from

Bacteroides intermedius, Bacteroides

gingivalis and Bacteroides loescheii. Oral Microbiology and

Immunology, 1988. 3" p. 22-27.

